AR collaborates with ERα in aromatase inhibitor-resistant breast cancer

Androgen receptor (AR) is an attractive target in breast cancer because of its frequent expression in all the molecular subtypes, especially in estrogen receptor (ER)-positive luminal breast cancers. We have previously shown a role for AR overexpression in tamoxifen resistance. We engineered ER-posi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Breast Cancer Res Treat
Prif Awduron: Rechoum, Yassine, Rovito, Daniela, Iacopetta, Domenico, Barone, Ines, Andò, Sebastiano, Weigel, Nancy L., O’Malley, Bert W., Brown, Powel H., Fuqua, Suzanne A. W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4337991/
https://ncbi.nlm.nih.gov/pubmed/25178514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3082-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg